Molbio Diagnostics, a pioneering in-vitro diagnostics (IVD) unicorn with a global footprint spread across over 70 countries through its Truenat® platform, today announced the launch of a strong collaboration with Niramai Health Analytix, a Bangalore-based deep-tech startup. This partnership aims to accelerate the adoption of
Goa-based Molbio Diagnostics, which provides innovative solutions for universal access to high-quality healthcare, announced that Temasek has invested $85 million in the company. Molbio is known for its game-changing Truenat® technology – a point-of-care, portable, battery-operated Real-Time PCR platform. Hailed globally as a high-impact breakthrough
The Government of India is all set to launch a special door-to-door TB screening initiative on 24 March 2022, globally observed as World TB Day. Under this initiative, over the next two to three weeks, health workers will be visiting the vulnerable population that is
Truenat, an innovative point of care Real-Time PCR platform manufactured by Goa-based Molbio Diagnostics, has received Emergency Use Authorization by the DCGI for their Nipah test. This is the first kit in India to receive regulatory approval to conduct tests for Nipah. Nipah virus (NiV) is
